(Q39976271)

16 September 2017

title

EFNS guidelines on disease-specific CSF investigations (English)

1 reference

16 September 2017

3

G Giovannoni

1 reference

16 September 2017

7

C Teunissen

1 reference

16 September 2017

8

H Tumani

1 reference

16 September 2017

F Deisenhammer

1

1 reference

16 September 2017

R Egg

2

1 reference

16 September 2017

B Hemmer

4

1 reference

16 September 2017

A Petzold

5

1 reference

16 September 2017

F Sellebjerg

6

1 reference

16 September 2017

EFSN

9

1 reference

16 September 2017

publication date

1 June 2009

1 reference

European Journal of Neurology

16 September 2017

published in

1 reference

16 September 2017

volume

16

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

760-770

1 reference

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Prednisolone (30-60 mg/day) for diseases other than AD decreases amyloid beta-peptides in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

CSF detection of the 14-3-3 protein in unselected patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Sources of error in use of beta-2 transferrin analysis for diagnosing perilymphatic and cerebral spinal fluid leaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Immunoblotting of transferrin in the identification of cerebrospinal fluid otorrhoea and rhinorrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Elevated levels of myelin basic protein in CSF in relation to auditory brainstem responses in Bell's Palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Cerebrospinal myelin basic protein in multiple sclerosis. Identification of two groups of patients with acute exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Low levels of the vascular endothelial growth factor in CSF from early ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Neurofilament protein levels in CSF are increased in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02595.X

10.1111/J.1468-1331.2009.02595.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference